Cognition Therapeutics, Inc.CGTXNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank40
3Y CAGR-18.5%
Studio
Year-over-Year Change

Price-to-book ratio

3Y CAGR
-18.5%/yr
Annual compound
Percentile
P40
Within normal range
vs 3Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive declineElevated
PeriodValueYoY Change
20241.49-34.4%
20232.27+49.8%
20221.51-44.8%
20212.74+166.7%
2020-4.11+14.3%
2019-4.79-